Page last updated: 2024-08-26

3,4-methylenedioxyethamphetamine and Mental Disorders

3,4-methylenedioxyethamphetamine has been researched along with Mental Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freudenmann, RW; Spitzer, M1
Borchardt, D; Gouzoulis, E; Hermle, L; Kovar, KA; Spitzer, M1
Arning, C; Buell, U; Gouzoulis-Mayfrank, E; Kaiser, HJ; Sabri, O; Sass, H; Schreckenberger, M; Wagenknecht, G; Zeggel, T; Zimny, M1

Reviews

1 review(s) available for 3,4-methylenedioxyethamphetamine and Mental Disorders

ArticleYear
The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA).
    CNS drug reviews, 2004,Summer, Volume: 10, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Drug Administration Schedule; Drug Interactions; Europe; Hallucinogens; Humans; Illicit Drugs; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Neurotoxins; North America

2004

Trials

2 trial(s) available for 3,4-methylenedioxyethamphetamine and Mental Disorders

ArticleYear
Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1993, Volume: 8, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Double-Blind Method; Female; Humans; Male; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Psychological Tests; Reference Values

1993
"Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET study.
    European journal of nuclear medicine, 1999, Volume: 26, Issue:12

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Cerebral Cortex; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Disorders; Middle Aged; Psychological Tests; Radionuclide Imaging; Radiopharmaceuticals

1999